Veradermics to Discuss Phase 3 VDPHL01 Trial Results
Veradermics will hold a conference call to discuss topline results from its Phase 3 ‘304’ clinical trial of VDPHL01 in males with mild-to-moderate pattern hair loss.
Veradermics will hold a conference call to discuss topline results from its Phase 3 ‘304’ clinical trial of VDPHL01 in males with mild-to-moderate pattern hair loss.